Skip to main content

Fellowship Program Faculty

Clinical Faculty:

Dr Lee

Dr. Eugene K. Lee (Program Director)

  • Urothelial Cancer - Open Radical Cystectomy (Conduit and Neobladder), Robotic Nephroureterectomy
  • Kidney Cancer - Nephrectomy (Radical, Partial, Open, Robotic, Laparoscopic)
  • Testicular Cancer - Radical Orchiectomy and RPLND
  • Penile Cancer - Penectomy and Inguinal lymphadenectomy
Dr Duchene

Dr. David A. Duchene 

  • Kidney Cancer - Nephrectomy (Radical, Partial, Open, Robotic, Laparoscopic)
  • Urothelial Cancer - Robotic Nephroureterectomy
  • Prostate Cancer - RALP
Dr Holzbeierlein

Dr. Jeffrey M. Holzbeierlein (Chair, Department of Urology)

  • Bladder Cancer - Radical Cystectomy (Conduit and Neobladder, Open and Robotic)
  • Kidney Cancer - Nephrectomy (Radical, Partial, Open, Robotic, Laparoscopic)
  • Testicular Cancer - Radical Orchiectomy and RPLND
  • Penile Cancer - Penectomy and Inguinal lymphadenectomy
Dr Mirza

Dr. Moben Mirza 

  • Urothelial Cancer - Radical Cystectomy (Conduit and Neobladder), Nephroureterectomy
  • Prostate Cancer - RALP
  • Kidney Cancer - Nephrectomy (Radical, Partial, Open, Robotic, Laparoscopic)
  • Testicular Cancer - Radical Orchiectomy and RPLND
  • Penile Cancer - Penectomy and Inguinal lymphadenectomy
Dr Taylor

Dr. John A. Taylor III

  • Urothelial Cancer - Radical Cystectomy (Conduit and Neobladder)
William Parker

Dr. William Parker

  • Prostate Cancer - Prostatectomy (Robotic, Retzius-sparing)
Dr Wyre

Dr. Hadley W. Wyre

  • Reconstructive Oncology - Post-radiation oncology
  • Reconstructive Urology - parastomal hernia repair, post-radical cystectomy ureteral stricture repair
  • Urothelial Cancer - Radical Cystectomy (Conduit and Neobladder), Nephroureterectomy
  • Kidney Cancer - Nephrectomy (Radical, Partial, Open, Robotic, Laparoscopic)
  • Testicular Cancer - Radical Orchiectomy and RPLND
  • Penile Cancer - Penectomy and Inguinal lymphadenectomy
Rahul Parikh

Dr. Rahul Parikh

  • GU Medical Oncology
Elizabeth Wulff-Burchfield

Dr. Elizabeth Wulff-Burchfield

  • GU Medical Oncology
  • Palliative Care
Xinglei Shen

Dr. Xinglei Shen 

  • GU Radiation Oncology
Dr. Roland Chen

Dr. Roland Chen

  • GU Radiation Oncology

Research Faculty

Dr Li Benyi Li, MD, PhD, focuses on signal transduction in prostate cancer. His areas of focus include the GSK3-beta pathway and inhibitors of this pathway. He has three full time post-docs in his laboratory and two research assistants. He has funding from several foundations and extramural sources.
Dr Holzbeierlein Jeffrey M. Holzbeierlein, MD is a surgeon-scientist. His laboratory focuses on the production and development of HSP90 inhibitors in prostate and bladder cancer. Dr. Holzbeierlein has a long track record of basic/translational science publications and is currently funded through an NIH R01.
Dr Lee Eugene K. Lee, MD, is a surgeon-scientist with a translational laboratory focusing on glucose metabolism in bladder cancer. He is the PI of two bladder cancer related investigator initiated clinical trials developed through laboratory-based concepts. Dr. Lee has been funded through the Urology Care Foundation, American Cancer Society Institutional Research Grant, BCAN, a Frontier's Pilot Grant and a University of Kansas Cancer Center Pilot Grant.
Dr Taylor John Taylor, III, MD is an accomplished surgeon-scientist. He serves as the Founder and Director of the Leo and Anne Albert Institute for Bladder Cancer Care and Research. Dr. Taylor has published extensively in the field of biomarkers and chemoresistance in bladder cancer. He is also an expert at mouse models in bladder cancer. Dr. Taylor is well known within the bladder cancer community and brings a team of researchers from the University of Connecticut to the University of Kansas Medical Center.
Jill Hamilton-Reeves Jill Hamilton-Reeves, PhD is a dietician 100% dedicated to clinical and translational research. Her interests focus on nutrition and lifestyle modification in Prostate Cancer survivors and in Prevention. In addition, she works with bladder cancer patients on preventing weight loss after cystectomy and with immunonutrition at the time of radical cystectomy. She correlates outcomes with bio and immune markers in her laboratory. Dr. Hamilton-Reeves is the national PI of the SWOG 1600 SIMMUNE trial.
Shellie Ellis Shellie Ellis, PhD is an expert in Health Policy & Management. She uses qualitative and quantitative research methodologies to improve the quality of cancer care delivery. Her main area of interest is in disparities in prostate cancer treatment, adoption of new technologies, and reimbursement issues in treatment decisions.
Jeff Thompson Jeffrey Thompson, PhD is a biostatistician who has a particular interest in urologic research. His focus is taking advantage of the massive amounts of biomedical data that are now available. In particular, he is interested in the development and application of multi-omic or trans-omic data integration methods to create biomarkers that are more accurate and generate additional biological insight by creating more holistic models.
Last modified: Jul 08, 2020
ID=x27808